Italian Pharma Company Selects Emerson to Enable Digital Transformation

FIS – Fabbrica Italiana Sintetici, a leading active pharmaceutical ingredients manufacturer, has selected Emerson (NYSE: EMR) to digitize operations and work processes at three manufacturing sites in Italy. With the $20 million (€16.1 million) contracts, Emerson will provide automation technology to help create a fully electronic manufacturing environment for increased efficiencies, quality, and regulatory compliance.